THE EUROPEAN PLATFORM FOR MEDICINES REPURPOSING
Repurposing already known medicines implies that pressing medical needs can be addressed in a well-timed and often less costly manner.
See more news and opportunities here
DRUG REPURPOSING OPPORTUNITIES
Patients are the driving force behind any repurposing project
If you are a patient representative looking to champion a new repurposing programme, we would like to talk to you. You can contact us here.
Sound scientific hypotheses are the seed to viable repurposing projects
If you have a drug repurposing idea you would like to share with us, please fill in this form. Our multidisciplinary scientific operations team will contact you back to explore onboarding opportunities to support your project no matter what stage of development it is in.
Advancing research policy is critical
Advancing research policy is critical to facilitate equitable access to repurposed medicines and contribute to make health systems more sustainable.
REMEDi4ALL offers a unique opportunity for funders
REMEDi4ALL offers a unique opportunity for funders to collaborate and support research with a high potential to translate into real solutions for patients and contribute to the sustainability of healthcare systems.
Repurposing
drugs as the
new normal
Developing a new medicine is a complex endeavour with uncertain outcomes. There is a growing interest among patients, clinicians and researchers to explore the potential use of existing medicines to address areas of unmet medical needs. REMEDi4ALL will bring together these entrepreneurs to create an ecosystem
where new connections can be established to test and validate existing medicines for a new purpose focusing attention on the critical steps of development. Ultimately, by involving the right experts at the right time, unlocking innovative tools to exploit existing data and generating a compliant incentivised process will allow for medicines repurposing to benefit those in need.
REMEDi4ALL Partners & Associated partners
Sign up to receive the latest project-related news and opportunities
You can unsubscribe at any time.